Neo-Lotan (Losartan Potassium)

Losartan Potassium, the active ingredient in Neo-Lotan, is an angiotensin II receptor blocker presented as an oral tablet for oral use. It helps lower elevated blood pressure and reduces strain on the heart, making it suitable for adults with hypertension, heart failure, or diabetic kidney disease.

GNH USA supplies Neo-Lotan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Losartan is an angiotensin II receptor blocker indicated for conditions involving the renin‑angiotensin system.

- Hypertension: reduces systolic and diastolic blood pressure, lowering cardiovascular risk. - Heart failure: improves symptoms and reduces hospitalizations by decreasing afterload. - Diabetic nephropathy: slows progression of kidney damage in patients with type 2 diabetes.

Losartan may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Headache: mild to moderate pain in the head region. - Fatigue: feeling unusually tired or weak.

Serious or Rare Side Effects: - Hyperkalemia: elevated potassium levels that may cause cardiac arrhythmia. - Renal impairment: worsening kidney function, indicated by increased creatinine. - Angioedema: swelling of face, lips, tongue, or throat that can obstruct breathing.

Before initiating Neo-Lotan, clinicians should consider several safety aspects.

- Blood pressure monitoring: check regularly to avoid excessive hypotension. - Renal function assessment: evaluate serum creatinine before initiating therapy. - Electrolyte surveillance: monitor potassium levels, especially in patients on potassium‑sparing diuretics. - Pregnancy considerations: avoid use during the second and third trimesters due to fetal risk. - Drug interactions: review concomitant medications for potential additive effects on potassium or renal function. - Store below 25°C: keep in the original pack, protect from moisture.

Losartan can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Aliskiren: combined use may increase risk of renal dysfunction and hyperkalemia. - Potassium supplements or potassium‑sparing diuretics: can cause dangerous hyperkalemia. - High‑dose NSAIDs: may reduce antihypertensive effect and worsen renal function.

Moderate Interactions (Monitor Closely): - ACE inhibitors: concurrent use may increase risk of hypotension and renal impairment. - Thiazide diuretics: may enhance antihypertensive effect, requiring dose adjustment. - Lithium: losartan can increase lithium levels, necessitating monitoring.